Affymetrix Licenses Nucleic Acid Patents to NimbleGen | GenomeWeb
This article has been updated from a previous version, which incorrectly reported that NimbleGen had licensed and planned to sell Affymetrix's microarrays.
 
NEW YORK (GenomeWeb News) – Affymetrix has granted NimbleGen a license to patents covering the manufacture, use, and sale of nucleic acid microarrays, the companies said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.